DekaBank Deutsche Girozentrale
STRO icon

DekaBank Deutsche Girozentrale’s Sutro Biopharma STRO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,100
Closed -$201K – 1476
2021
Q3 		$201K Hold
1,100
– – ﹤0.01% 1207
2021
Q2 		$196K Hold
1,100
– – ﹤0.01% 1223
2021
Q1 		$228K Hold
1,100
– – ﹤0.01% 1162
2020
Q4 		$233K Buy
+1,100
New +$182K ﹤0.01% 1161

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

DekaBank Deutsche Girozentrale's STRO Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Sutro Biopharma (STRO) in Q4 2021, closing a stake of 1,100 shares — an estimated $201K sold.

DekaBank Deutsche Girozentrale first reported a position in STRO in Q4 2020 and held it in 4 quarters. The position peaked at $233K in Q4 2020. 117 funds tracked by Wall St. Rank hold STRO as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Sutro Biopharma position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,100 Sutro Biopharma shares in Q4 2021, an estimated $201K.
  • DekaBank Deutsche Girozentrale first reported a position in Sutro Biopharma in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Sutro Biopharma position peaked at $233K in Q4 2020.
  • 117 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.